Triple-negative breast cancer (TNBC), characterized by negative ER, PR, and human epidermal growth factor receptor-2 (HER-2), presents unique biological behaviors with poor prognosis due to the lack of effective targeted therapy. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.